Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study.

M L MorieriI RazA ConsoliM RigatoA LapollaF BroglioE BonoraA AvogaroGian Poalo Fadininull null

Published in: Journal of endocrinological investigation (2023)

Elderly patients with T2D initiating dapagliflozin had a lower probability of achieving individualized HbA1c targets than those initiating DPP-4 inhibitors but displayed better improvements in extra-glycaemic endpoints.

Keyphrases

middle aged
community dwelling
type diabetes
randomized controlled trial
systematic review
clinical trial
study protocol
double blind